GSS Antibody

Shipped with Ice Packs
In Stock

Description

Biological Role of GSS

GSS catalyzes the ATP-dependent condensation of γ-glutamylcysteine and glycine to form glutathione (GSH), a tripeptide vital for:

  • Neutralizing reactive oxygen species (ROS)

  • Xenobiotic detoxification

  • Maintaining redox balance in cellular compartments
    Mutations in the GSS gene cause glutathione synthetase deficiency, linked to hemolytic anemia, neurological dysfunction, and 5-oxoprolinuria .

Neurodegeneration in Prion Diseases

  • Gerstmann–Sträussler–Scheinker (GSS) Disease: Anti-GSS antibodies identified dopaminergic neuron loss in GSS-P102L cases, correlating with prion protein (PrP) plaque deposition in the substantia nigra .

    • Key Observation: DAT immunoreactivity (a dopamine transporter marker) was absent in GSS-affected putamen, while PrP plaques dominated .

    • Mechanism: PrP aggregation disrupts redox homeostasis, exacerbating oxidative damage .

Fertility Impairment via Ferroptosis

  • Study: Gss knockout mice exhibited age-dependent infertility due to testicular ferroptosis .

    • Role of GSS Antibodies: Confirmed reduced GPX4 (ferroptosis inhibitor) and elevated ALOX15 (pro-oxidant) in testes, linking GSH depletion to lipid peroxidation .

    • Impact: ROS accumulation impaired spermatogenesis, reversible via antioxidant treatment .

Strain-Specific Prion Transmission

  • Bank Vole Model: GSS-associated PrP<sup>res</sup> isoforms (6–8 kDa) transmitted prion pathology efficiently, challenging prior assumptions about non-transmissibility .

    • Phenotypes: Distinct survival periods correlated with PrP<sup>res</sup> fragment sizes (7 kDa: 180–250 days; 21 kDa: >600 days) .

Applications in Biomedical Research

  • Western Blotting: Detects GSS at ~52 kDa in human liver, mouse brain, and HEK-293 lysates .

  • Immunohistochemistry: Localizes GSS in renal tubules (human kidney) and neuronal populations .

  • Functional Studies:

    • Validates CRISPR/Cas9 knockout efficiency

    • Screens drug candidates targeting glutathione metabolism

Limitations and Considerations

  • Species Cross-Reactivity: Mouse-derived antibodies (e.g., ANT-645) may lack reactivity in non-human primates .

  • Storage Stability: Glycerol-based formulations (e.g., Proteintech’s 50% glycerol buffer) prevent freeze-thaw damage but require -20°C storage .

  • Ethical Restrictions: Commercial GSS antibodies are labeled "For Research Use Only," excluding diagnostic or therapeutic applications .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
We typically dispatch orders within 1-3 business days of receipt. Delivery times may vary based on shipping method and destination. Please contact your local distributor for specific delivery timeframes.
Synonyms
epididymis secretory sperm binding protein Li 64p antibody; epididymis secretory sperm binding protein Li 88n antibody; Glutathione synthase antibody; Glutathione synthetase antibody; GSH S antibody; GSH synthetase antibody; GSH-S antibody; GSHB_HUMAN antibody; GSHS antibody; GSS antibody; HEL-S-64p antibody; HEL-S-88n antibody; MGC14098 antibody; OTTHUMP00000030711 antibody
Target Names
GSS
Uniprot No.

Target Background

Function
This antibody catalyzes the production of glutathione from gamma-glutamylcysteine and glycine in an ATP-dependent manner. Glutathione (gamma-glutamylcysteinylglycine, GSH) is the most abundant intracellular thiol in living aerobic cells. It plays a vital role in numerous cellular processes, including protection against oxidative damage, amino acid transport, detoxification of foreign compounds, maintenance of protein sulfhydryl groups in a reduced state, and acts as a cofactor for a number of enzymes.
Gene References Into Functions
  1. Research indicates that clusterin and glutathione synthetase (GSH-S) hold potential as platelet biomarkers for early detection of colorectal cancer (CRC). Their use could enhance existing screening modalities in clinical practice. PMID: 28849249
  2. Mutations in the Glutathione Synthase gene have been linked to chronic metabolic acidosis in glutathione synthetase deficiency. PMID: 26669244
  3. Four single nucleotide polymorphisms (SNPs) (rs7265992, rs6060124, rs7260770, and rs4911455) in the GSS gene have been significantly associated with bladder cancer recurrence after transurethral resection and BCG treatment. PMID: 25851338
  4. This study investigated clinical, biochemical, and genetic aspects of five Chinese patients with 5-oxoprolinuria, a condition caused by mutations in either the OPLAH or GSS genes. PMID: 25851806
  5. The study investigated the role of protein-protein interactions in the structural stability, activity, and allostery of enzymes using the obligate homodimer human glutathione synthetase as a model. PMID: 25070563
  6. The findings indicate that Asp458 is essential for hGS catalysis and that it impacts the allostery of hGS. PMID: 21771585
  7. These results imply that residues V44 and V45 are crucial for the stability of human glutathione synthetase. PMID: 21683691
  8. This study demonstrated that susceptibility to health effects of air pollution on lung function growth is associated with genetic variation in the GSS gene. PMID: 20802163
  9. Single-nucleotide polymorphism in glutathione synthetase has been linked to small-cell lung cancer. PMID: 20439344
  10. Research indicates that Gly369 and Gly370 play essential roles in hGS, while Gly371 has a lesser involvement. PMID: 20800579
  11. The study suggests that the cause of cellular ATP depletion in nephrotic cystinosis may be a futile cycle formed between two ATP-dependant gamma-glutamyl cycle enzymes, gamma-glutamyl cysteine synthetase and 5-oxoprolinase. PMID: 20413906
  12. A novel alternative splicing variant (ASV) of the GSS gene was identified in 10 human normal tissues and five human cancer cell lines. PMID: 19672693
  13. Glutathione synthetase deficiency: is gamma-glutamylcysteine accumulation a mechanism for cells to cope with oxidative stress when glutathione levels are insufficient? PMID: 12638941
  14. An analysis of conserved residues of human glutathione synthetase was conducted. PMID: 14990577
  15. This report describes the cloning and characterization of a 2.2 kb 5'-flanking region of the human glutathione synthetase gene. PMID: 15890065
  16. Autosomal mutations in the glutathione synthetase gene result in glutathione synthetase deficiency, which can lead to progressive retinal dystrophy with hyperpigmentations and maculopathy. PMID: 17206463
  17. Glutathione synthase expression may be associated with better survival in early-stage adenocarcinoma of the lung. Manipulating glutathione synthase may offer a potential basis for treating certain non-small cell lung cancers. PMID: 17234469
  18. Severe glutathione synthetase deficiency is linked to progressive retinal dystrophy of the rod-cone type, affecting the central retina with advanced macular edema in adulthood. PMID: 19111905

Show More

Hide All

Database Links

HGNC: 4624

OMIM: 231900

KEGG: hsa:2937

STRING: 9606.ENSP00000216951

UniGene: Hs.82327

Involvement In Disease
Glutathione synthetase deficiency (GSS deficiency); Glutathione synthetase deficiency of erythrocytes (GLUSYNDE)
Protein Families
Eukaryotic GSH synthase family

Q&A

What is the molecular weight of the GSS protein, and how does this affect antibody detection methods?

GSS (glutathione synthetase) is a 52 kDa protein composed of 474 amino acids, encoded by a gene located on human chromosome 20q11.2 . When working with GSS antibodies, researchers should expect to observe bands at approximately 52 kDa in Western blot applications. This molecular weight consistency has been confirmed across multiple antibody products and serves as a primary validation point . The homodimeric structure of functional GSS should be considered when designing experiments, as this may affect epitope accessibility in certain applications.

What range of applications are validated for commercially available GSS antibodies?

GSS antibodies have been extensively validated for multiple applications, with different antibodies showing varying performance profiles:

  • Western Blot (WB): Recommended dilutions range from 1:500-1:50000 depending on the specific antibody

  • Immunohistochemistry (IHC): Typical dilutions of 1:50-1:2000

  • Immunofluorescence (IF)/ICC: Optimal dilutions between 1:50-1:800

  • Flow Cytometry: Validated with dilutions around 1:50-1:100

  • ELISA: Validated for multiple antibody products

Each application requires specific optimization, and researchers should titrate the antibody in their particular testing system to obtain optimal results .

What are the recommended antigen retrieval methods for IHC applications with GSS antibodies?

For optimal GSS detection in IHC applications, two primary antigen retrieval methods have been validated:

  • TE buffer pH 9.0 (preferred method for several antibodies)

  • Citrate buffer pH 6.0 (alternative method)

For paraffin-embedded tissues, specific protocols have been validated for mouse lung tissue and human liver cancer tissue . The choice between these methods may depend on tissue type and fixation procedure, with some antibodies showing differential performance with each method. Researchers should empirically determine the optimal retrieval method for their specific tissue samples.

What cell lines serve as positive controls for GSS antibody validation?

Multiple cell lines have been validated as positive controls for GSS antibody testing:

Western Blot Positive ControlsImmunofluorescence Positive Controls
CHO cells HeLa cells
HEK-293 cells MDCK cells
HeLa cells A549 cells
HepG2 cells Jurkat cells
Jurkat cells
SiHa cells

These validated cell lines provide reliable positive controls for antibody characterization experiments .

How does species cross-reactivity impact experimental design with GSS antibodies?

GSS antibodies show varying cross-reactivity profiles across species, which must be considered in experimental design:

Antibody Catalog #Validated Species Reactivity
67598-1-IgHuman, Mouse, Rat, pig, hamster
15712-1-APHuman, mouse, rat, pig, canine, hamster
A00928-1Human, Mouse, Rat
161654Human, Mouse, Rat

For cross-species studies, researchers should select antibodies with validated reactivity in their target species. When working with non-validated species, preliminary validation experiments should be conducted to confirm reactivity and specificity .

What approaches can be used to validate antibody specificity for GSS versus related proteins?

Ensuring antibody specificity for GSS requires rigorous validation approaches:

  • Epitope mapping: Several antibodies target specific regions of GSS, such as C-terminal region-specific antibodies , providing higher specificity.

  • Cross-reactivity testing: High-quality GSS antibodies should show "no cross-reactivity with other proteins" , which can be validated through:

    • Western blot analysis with positive and negative control lysates

    • Immunoprecipitation followed by mass spectrometry

    • Competition assays with purified recombinant GSS protein

  • Biophysics-informed modeling: Recent advancements utilize "biophysics-informed modeling" to identify distinct binding modes associated with specific ligands, enabling the design of antibodies with customized specificity profiles .

How can GSS antibodies be utilized in studies of glutathione synthesis disorders?

GSS plays a critical role in the glutathione biosynthesis pathway, catalyzing the ATP-dependent condensation of γ-glutamylcysteine and glycine to form glutathione . Defects in GSS cause glutathione synthetase deficiency (also known as 5-oxoprolinuria or pyroglutamic aciduria), characterized by central nervous system damage, hemolytic anemia, and metabolic acidosis .

For studying these disorders, researchers can employ GSS antibodies in:

  • Tissue expression profiling: IHC analysis of GSS expression in affected tissues

  • Biochemical analysis: Quantifying GSS protein levels in patient samples by Western blot

  • Subcellular localization: Using IF/ICC to determine GSS distribution in affected cells

  • Protein-protein interaction studies: Immunoprecipitation to identify altered binding partners in disease states

These approaches can provide insights into the cellular mechanisms underlying GSS deficiency disorders.

What methods exist for generating antibodies with customized GSS specificity profiles?

Recent advances in antibody engineering have enabled the development of GSS antibodies with customized specificity profiles:

  • Biophysics-informed modeling: This approach combines "high-throughput sequencing and downstream computational analysis" to identify different binding modes associated with particular ligands, allowing for the design of antibodies with either:

    • Specific high affinity for a particular target ligand

    • Cross-specificity for multiple target ligands

  • Phage display optimization: Experiments involving "antibody selection against diverse combinations of closely related ligands" can generate variants with defined specificity profiles not present in initial libraries .

  • Computational prediction: Models trained on experimentally selected antibodies can predict outcomes for new ligand combinations and generate novel antibody variants with desired specificity .

These advanced methods allow researchers to design GSS antibodies with precisely defined binding characteristics for specialized research applications.

How can experimental artifacts in GSS antibody applications be mitigated?

To minimize experimental artifacts when working with GSS antibodies:

  • Include multiple controls:

    • Positive controls: Use validated cell lines known to express GSS (e.g., HeLa, CHO cells)

    • Negative controls: Include isotype controls and/or GSS-deficient samples

    • Blocking peptides: For certain antibodies, specific blocking peptides are available to confirm specificity

  • Optimize protocols for specific applications:

    • For Western blot: Optimize blocking buffers (e.g., "3% nonfat dry milk in TBST")

    • For IHC: Test multiple antigen retrieval methods (TE buffer pH 9.0 or citrate buffer pH 6.0)

    • For IF: Optimize fixation methods and permeabilization conditions

  • Apply biophysics-informed modeling: This approach can help "mitigate experimental artifacts and biases in selection experiments" by identifying and disentangling multiple binding modes .

What are the optimal storage conditions for maintaining GSS antibody activity?

Proper storage is critical for maintaining GSS antibody performance over time:

  • Storage temperature:

    • Long-term storage: -20°C is recommended for most GSS antibodies

    • Short-term storage (up to 1 month): 4°C is acceptable for many antibodies

  • Storage buffer composition:

    • Most GSS antibodies are supplied in PBS with:

      • 0.02% sodium azide as preservative

      • 50% glycerol to prevent freeze/thaw damage

      • pH 7.3 for optimal stability

    • Some formulations include 0.1% BSA for additional stability

  • Aliquoting considerations:

    • For most -20°C storage, aliquoting is unnecessary

    • Avoid repeated freeze/thaw cycles which can reduce antibody activity

Following these guidelines ensures maintenance of antibody specificity and sensitivity over time.

What dilution ranges should be used for different experimental applications?

GSS antibodies require specific dilution ranges for optimal performance in different applications:

ApplicationRecommended Dilution Ranges
Western Blot1:500-1:50000
IHC1:50-1:2000
IF/ICC1:50-1:800
Flow Cytometry1:50-1:100
ELISAApplication-specific

Importantly, researchers should "titrate each reagent to obtain optimal results" as performance can be sample-dependent . For Western blot applications, dilution optimization should consider factors like total protein loaded (typically 25-40μg per lane) and detection method (ECL, fluorescence-based).

How can GSS antibodies be used to study redox regulation in cellular systems?

GSS plays a vital role in glutathione synthesis, a key antioxidant that "protects cells from oxidative stress and maintains cellular redox balance" . GSS antibodies enable sophisticated studies of redox regulation:

  • Subcellular localization studies: GSS antibodies can be used to track changes in subcellular distribution of GSS in response to oxidative stress using immunofluorescence .

  • Protein-protein interaction networks: Immunoprecipitation with GSS antibodies can identify stress-induced changes in GSS interaction partners.

  • Expression level correlation: Combining GSS antibodies with antibodies against other redox-regulating proteins allows researchers to map coordinated expression changes across redox networks.

  • Stress response kinetics: Western blot analysis with GSS antibodies can quantify temporal changes in GSS expression following various oxidative insults, providing insights into cellular adaptive responses.

What are the emerging applications of computational modeling in GSS antibody design?

Recent developments in computational approaches are revolutionizing GSS antibody design:

  • Biophysics-informed modeling: This approach identifies "different binding modes, each associated with a particular ligand," enabling prediction and generation of specific variants beyond those observed in experiments .

  • Machine learning integration: Combining experimental data with computational models allows researchers to "predict outcomes for another [ligand combination]" and generate antibody variants with customized specificity profiles .

  • Binding mode disentanglement: Advanced computational tools can distinguish between binding modes associated with chemically similar ligands, enabling precise control over antibody specificity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.